Radiation effects on silicon Fourth quarterly progress report, Sep. 25 - Dec. 31, 1965

Radiation effects in silicon solar cell

Radiation effects on silicon Quarterly progress report, 1 Jul. - 30 Sep. 1966

Electrical conductivity and electron spin resonance experiments in study of radiation effects on silico

Radiation effects on silicon Summary report 1 Nov. 1965 - 20 Apr. 1967

Radiation-induced displacement effects measured in n and p type, low and high resistivity silico

Radiation effects on silicon Sixth quarterly progress report, Apr. 1 - Jun. 30, 1966

Radiation effects on high purity n-type silicon solar cell

Radiation effects on silicon solar cells Fourth monthly progress report, Apr. 1-30, 1962

Radiation effects on silicon solar cell

Radiation effects on silicon solar cells Final report, Dec. 1, 1961 - Dec. 31, 1962

Displacement defects in silicon solar cells by high energy electron irradiation using electron spin resonance, galvanometric, excess carrier lifetime, and infrared absorption measurement

Is there a role for melatonin in fibromyalgia?

Fibromyalgia, characterised by persistent pain, fatigue, sleep disturbance and cognitive dysfunction, is a central sensitivity syndrome that also involves abnormality in peripheral generators and in the hypothalamic pituitary adrenal axis. Heterogeneity of clinical expression of fibromyalgia with a multifactorial aetiology has made the development of effective therapeutic strategies challenging. Physiological properties of the neurohormone melatonin appear related to the symptom profile exhibited by patients with fibromyalgia and thus disturbance of it’s production would be compatible with the pathophysiology. Altered levels of melatonin have been observed in patients with fibromyalgia which are associated with lower secretion during dark hours and higher secretion during daytime. However, inconsistencies of available clinical evidence limit conclusion of a relationship between levels of melatonin and symptom profiles in patients with fibromyalgia. Administration of melatonin to patients with fibromyalgia has demonstrated suppression of many symptoms and an improved quality of life consistent with benefit as a therapy for the management of this condition. Further studies with larger samples, however, are required to explore the potential role of melatonin in the pathophysiology of fibromyalgia and determine the optimal dosing regimen of melatonin for the management of fibromyalgia